Nisa Investment Advisors’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,383
| Closed | -$1.77K | – | 3089 |
|
|
2025
Q4 | $1.77K | Sell |
1,383
-3,396
| -71% | -$4.56K | ﹤0.01% | 2628 |
|
|
2025
Q3 | $6.21K | Buy |
4,779
+256
| +6% | +$335 | ﹤0.01% | 2398 |
|
|
2025
Q2 | $5.43K | Sell |
4,523
-233
| -5% | -$258 | ﹤0.01% | 2429 |
|
|
2025
Q1 | $5.14K | Sell |
4,756
-212
| -4% | -$298 | ﹤0.01% | 2246 |
|
|
2024
Q4 | $8.69K | Sell |
4,968
-13,160
| -73% | -$24.5K | ﹤0.01% | 2164 |
|
|
2024
Q3 | $35K | Buy |
18,128
+14,732
| +434% | +$28.9K | ﹤0.01% | 1736 |
|
|
2024
Q2 | $6.01K | Sell |
3,396
-6,285
| -65% | -$15.4K | ﹤0.01% | 2247 |
|
|
2024
Q1 | $26.2K | Buy |
+9,681
| New | +$23.4K | ﹤0.01% | 1805 |
|
|
2022
Q3 | – | Sell |
-1,335
| Closed | -$2K | – | 2614 |
|
|
2022
Q2 | $2K | Hold |
1,335
| – | – | ﹤0.01% | 2344 |
|
|
2022
Q1 | $5K | Hold |
1,335
| – | – | ﹤0.01% | 2311 |
|
|
2021
Q4 | $4K | Hold |
1,335
| – | – | ﹤0.01% | 2105 |
|
|
2021
Q3 | $9 | Hold |
1,335
| – | – | ﹤0.01% | 2215 |
|
|
2021
Q2 | $8 | Hold |
1,335
| – | – | ﹤0.01% | 2250 |
|
|
2021
Q1 | $6 | Hold |
1,335
| – | – | ﹤0.01% | 2251 |
|
|
2020
Q4 | $8K | Hold |
1,335
| – | – | ﹤0.01% | 2242 |
|
|
2020
Q3 | $10K | Hold |
1,335
| – | – | ﹤0.01% | 2122 |
|
|
2020
Q2 | $5K | Buy |
1,335
+275
| +26% | +$958 | ﹤0.01% | 2007 |
|
|
2020
Q1 | $3K | Buy |
+1,060
| New | +$3.48K | ﹤0.01% | 2007 |
|
|
2019
Q4 | – | Sell |
-23,200
| Closed | -$107K | – | 2024 |
|
|
2019
Q3 | $107K | Sell |
23,200
-8,400
| -27% | -$66.2K | ﹤0.01% | 1447 |
|
|
2019
Q2 | $389K | Hold |
31,600
| – | – | ﹤0.01% | 1155 |
|
|
2019
Q1 | $420K | Hold |
31,600
| – | – | ﹤0.01% | 1113 |
|
|
2018
Q4 | $272K | Hold |
31,600
| – | – | ﹤0.01% | 1161 |
|
|
2018
Q3 | $237K | Hold |
31,600
| – | – | ﹤0.01% | 1274 |
|
|
2018
Q2 | $188K | Hold |
31,600
| – | – | ﹤0.01% | 1274 |
|
|
2018
Q1 | $207K | Buy |
31,600
+8,400
| +36% | +$55.2K | ﹤0.01% | 1227 |
|
|
2017
Q4 | $137K | Hold |
23,200
| – | – | ﹤0.01% | 1331 |
|
|
2017
Q3 | $117K | Buy |
+23,200
| New | +$97.5K | ﹤0.01% | 1347 |
|
|
2016
Q4 | – | Sell |
-1,000
| Closed | -$8K | – | 1883 |
|
|
2016
Q3 | $8K | Hold |
1,000
| – | – | ﹤0.01% | 1809 |
|
|
2016
Q2 | $9K | Hold |
1,000
| – | – | ﹤0.01% | 1798 |
|
|
2016
Q1 | $8K | Buy |
+1,000
| New | +$7.21K | ﹤0.01% | 1802 |
|
Other funds holding LAB
CC
MCO
LFCM
VCM
HBWM
Nisa Investment Advisors's LAB Position: Q1 2026 in Review
Nisa Investment Advisors sold out of Standard BioTools (LAB) in Q1 2026, closing a stake of 1,383 shares — an estimated $1.77K sold.
Nisa Investment Advisors first reported a position in LAB in Q1 2016 and held it in 30 quarters. The position peaked at $420K in Q1 2019. 156 funds tracked by Wall St. Rank hold LAB as of Q1 2026.
- Nisa Investment Advisors reported no remaining Standard BioTools position as of Q1 2026 after selling out during the quarter.
- Nisa Investment Advisors sold 1,383 Standard BioTools shares in Q1 2026, an estimated $1.77K.
- Nisa Investment Advisors first reported a position in Standard BioTools in Q1 2016 and held it in 30 quarters.
- Nisa Investment Advisors's Standard BioTools position peaked at $420K in Q1 2019.
- 156 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.
Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.